Banking on treatment | Addiction Professional Magazine Skip to content Skip to navigation

Banking on treatment

December 1, 2008
by John S. Castle
| Reprints
An outside investor explains its interest in one of the treatment field's fast-growing providers

Other investors could join

Branford is keenly interested in continuing to fund Townsend's growth as well as in helping it raise capital from additional investors. One of Branford's key capabilities as a financing source is that it is not a limited partnership fund, and is not subject to pressures that force “financial buyers” to sell in a reasonably short period of time.

We have selected a “buy, grow, and hold” strategy that offers sellers the potential for short- and long-term stability for a business post-transaction. We are partnered with Townsend for the long haul.

John S. Castle is Senior Vice President of Branford Castle, Inc., a New York City-based long-term investor in small to medium-sized “old economy” businesses, as it describes in its corporate communications. The platform investments of the company, which was founded in 1986, typically fall in the $10 million to $40 million enterprise value range. Branford Castle's chairman and founder is the CEO of Castle Harlan, a New York City-based private equity investment firm. Castle's e-mail address is


For the perspectives of Townsend Recovery's medical director on comprehensive treatment that includes medications, visit

Addiction Professional 2008 December;6(7):8-10